• Testosterone Bounce as a Prognostic Biomarker in Prostate Ca

  2026-05-22

  Akakura et al. (2024) demonstrate that testosterone bounce—a transient rise in serum testosterone above 20 ng/dL after initial suppression—predicts improved overall and cancer-specific survival in prostate cancer patients treated with degarelix. This finding establishes testosterone bounce as a clinically actionable prognostic marker, enhancing assessment beyond traditional PSA monitoring in hormone therapy contexts.

• PAD4-IN-2 TFA: Redefining Tumor-Selective NET Inhibition

  2026-05-22

  Discover how PAD4-IN-2 TFA advances tumor-targeted inhibition of histone H3 citrullination and NET formation. This in-depth analysis reveals distinct mechanistic insights and practical guidance for leveraging Compound 5i TFA in cutting-edge cancer research.

• AEBSF.HCl: Optimizing Protease Inhibition in Cell Death Assa

  2026-05-21

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) is redefining the toolkit for researchers investigating protease-driven cell death and amyloid precursor protein processing. This article delivers actionable protocol upgrades, troubleshooting strategies, and a translational bridge from recent necroptosis research to practical laboratory workflows.

• CX-4945 (Silmitasertib): Selective CK2 Inhibition in Cancer

  2026-05-21

  CX-4945 (Silmitasertib) is a potent, ATP-competitive inhibitor of casein kinase 2 (CK2) with nanomolar activity. It precisely targets both CK2α and CK2α', driving apoptosis and cell cycle arrest in cancer models while showing promise for host-directed antiviral strategies. This article details the mechanism, evidence, and application limits of CX-4945, with a focus on rigorous, verifiable facts.

• Assessing pH-Dependent Interactions of Ribociclib Succinate

  2026-05-20

  This study introduces a robust analytical Quality by Design (QbD) approach to evaluate potential pH-mediated drug interactions between ribociclib succinate and acid-reducing agents. The findings indicate that clinically relevant pH shifts do not significantly impact the solubility or absorption of ribociclib succinate, supporting its flexible use in cancer research protocols.

• Direct Mouse Genotyping Kit: Rapid PCR From Mouse Tissue

  2026-05-20

  The Direct Mouse Genotyping Kit enables fast, purification-free PCR amplification directly from mouse tissue lysates, streamlining genotyping workflows for biomedical research. This product is ideal for high-throughput screening and routine genetic validation, but may be unsuitable for applications requiring highly purified or intact genomic DNA for downstream analyses beyond PCR. Users should adhere to optimized storage and handling practices to maintain reagent integrity.

• Zosuquidar (LY335979): Transforming MDR Research in Oncology

  2026-05-19

  This thought-leadership article explores how Zosuquidar (LY335979) 3HCl, a potent and selective P-glycoprotein (P-gp) inhibitor, is revolutionizing translational oncology research. By integrating mechanistic insights, best-practice experimental strategies, and recent pharmacokinetic discoveries—including the interplay between P-gp modulation and drug disposition—this guide offers strategic frameworks for harnessing Zosuquidar in multidrug resistance (MDR) reversal. With evidence-backed recommendations, it positions APExBIO’s Zosuquidar as a cornerstone tool for overcoming chemotherapy resistance, optimizing preclinical models, and advancing clinical pipeline decisions.

• Angiotensin II in Vascular Aging and Remodeling Research

  2026-05-19

  Angiotensin II empowers precise modeling of vascular senescence and cardiovascular remodeling, enabling researchers to dissect mitochondrial dysfunction and hypertrophy pathways. Recent breakthroughs clarify its role in endothelial aging, while optimized protocols from APExBIO ensure reproducibility and translational relevance.

• Luminescent ATP Cell Viability Assay Kit I: Enabling Mechani

  2026-05-18

  Discover how the Luminescent ATP Cell Viability Assay Kit I empowers researchers with ultra-sensitive luciferase luminescence detection for precise cell viability measurement, uniquely suited for dissecting regulated cell death mechanisms such as ferroptosis. This article dives into assay mechanisms, comparative advantages, and practical guidance for advanced cell biology studies.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Protocol and

  2026-05-18

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses protein degradation during extraction and analysis, especially where divalent cation sensitivity is a concern. It is best suited for workflows like Western blotting, co-immunoprecipitation, and kinase assays but should not be used where EDTA is required for metalloprotease inhibition.

• High-Concentration LNPs Enhance In Vivo mRNA Expression and

  2026-05-17

  This study demonstrates that increasing the concentration of lipid mixtures during LNP formulation leads to improved in vivo gene expression and greater storage stability of mRNA-LNPs. The findings offer valuable guidance for optimizing mRNA delivery systems, with implications for both therapeutic development and reporter gene assay design.

• Zosuquidar (LY335979) 3HCl: Precision P-gp Inhibition for Tr

  2026-05-16

  Explore the multifaceted role of Zosuquidar (LY335979) 3HCl, a potent P-gp inhibitor, in overcoming multidrug resistance (MDR) in cancer. This article delivers advanced assay guidance, interprets recent transporter research, and uniquely integrates pharmacokinetic insights to inform translational oncology workflows.

• Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto

  2026-05-15

  This study uncovers a methyltransferase-dependent mechanism by which Salmonella Typhimurium enhances its own haem biosynthesis to inhibit macrophage phagocytosis, thereby promoting virulence in mice. The findings reveal a new layer of immune evasion and highlight haem as a critical modulator of host-pathogen interactions, with implications for research on bacterial immune evasion and heme biosynthesis.

• 6-Thioguanine Suppresses EV71 Replication via BIRC3-Autophag

  2026-05-15

  A recent study demonstrates that 6-thioguanine (6-TG) inhibits replication of enterovirus 71 (EV71) by reducing BIRC3-mediated autophagy in vitro. These findings clarify a previously unexplored antiviral mechanism and suggest new lines of investigation for antiviral drug development targeting autophagy pathways.

• Panobinostat (LBH589): Broad-Spectrum HDAC Inhibitor Evidenc

  2026-05-14

  Panobinostat (LBH589) is a potent hydroxamic acid-based HDAC inhibitor used in epigenetic regulation research and apoptosis induction in cancer cells. This article reviews its mechanisms, quantitative efficacy, and protocol parameters with verified citations. APExBIO supplies Panobinostat under SKU A8178 for advanced experimental workflows.

14669 records 1/978 page Next 12345 下5页 Last page